CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript May 15, 2023
CymaBay Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.29 EPS, expectations were $-0.09.
Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks today, we will open up the call for your questions. Please be...
